Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,494
Total Claims
$667K
Drug Cost
325
Beneficiaries
$2,053
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
+45%
Cost per patient vs peers
$2,053 vs $1,411 avg
+12%
Brand preference vs peers
12.0% vs 10.6% avg
Brand vs Generic
Brand: 1,354 claims · $523K
Generic: 9,971 claims · $139K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Sitagliptin Phosphate | 140 | $104K |
| Insulin Glargine,hum.Rec.Anlog | 103 | $51K |
| Dulaglutide | 40 | $44K |
| Empagliflozin | 43 | $35K |
| Apixaban | 33 | $26K |
| Levothyroxine Sodium | 390 | $25K |
| Insulin Lispro | 38 | $22K |
| Insulin Nph Human Isophane | 45 | $20K |
| Rivaroxaban | 21 | $18K |
| Dapagliflozin Propanediol | 27 | $16K |
| Insulin Nph Hum/Reg Insulin Hm | 34 | $13K |
| Sitagliptin Phos/Metformin Hcl | 13 | $12K |
| Dapaglifloz Propaned/Metformin | 12 | $8,264 |
| Canagliflozin | 13 | $7,665 |
| Atorvastatin Calcium | 633 | $6,481 |
Prescribing Profile
Patient Profile
71
Avg Age
62%
Female
1.67
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data